MGMT and glioblastoma: The ICI ipilimumab and nivolumab combination is now being retested in a phase II/III study in newly diagnosed MGMT unmethylated GBM patients, comparing the usual treatment with radiation therapy and TMZ to radiation therapy in combination with ipilimumab and nivolumab (NCT04396860).